» Articles » PMID: 38100030

A Rare Case of Primary Central Nervous System Histiocytic Sarcoma Harboring a Novel ARHGAP45::BRAF Fusion: a Case Report and Literature Review

Overview
Date 2023 Dec 15
PMID 38100030
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Patients with histiocytic sarcoma occurring in the central nervous system (CNS) are rare and have a very poor prognosis. The increased use of molecular diagnostic approaches in solid tumors has brought more opportunities for the diagnosis and treatment of central nervous system histiocytic sarcoma (CNSHS).

Case Description: A 9-year-old girl was admitted to the hospital with pain in her head and neck, as well as vomiting. Imaging scans showed a prominent abnormality in the anterior falciform region, and histopathology revealed the presence of CD68 (+) and CD163 (+) cells, leading to a preliminary diagnosis of primary intracerebral CNSHS. Molecular profiling tests identified a new variant of ARHGAP45::BRAF fusion in this case, which has not been reported in any other tumor. The patient underwent surgical removal of the tumor and will require long-term monitoring.

Conclusion: The presence of the BRAF point mutation, predominantly BRAF p.V600E, has been documented in prior literature of CNSHS. This is the first case of pediatric histiocytic sarcoma in the anterior falciform region who has a unique ARHGAP45::BRAF fusion. The findings of our study indicate that a broader range of molecular assays should be employed in the diagnosis of CNSHS and opens up new possibilities for the treatment of the patient.

Citing Articles

Clinicopathological and molecular characterization of astrocytoma.

Wu X, Peng W, Zhang X, Tang T, Deng L, Xu Y Front Mol Neurosci. 2025; 18:1483833.

PMID: 39963393 PMC: 11830656. DOI: 10.3389/fnmol.2025.1483833.


Novel :: Gene Fusion in Infantile Fibrosarcoma: A Case Report and Review of Literature.

Gonzalez-Lopez J, Rubio-Martinez L, Atares M, Amaya J, Huart M, Mayordomo-Aranda E Int J Mol Sci. 2025; 26(3).

PMID: 39940949 PMC: 11818928. DOI: 10.3390/ijms26031182.


Case report: Treatment of a rare primary cerebellum histiocytic sarcoma with surgery and radiotherapy.

Yanchu L, Li Z, Qiongwen Z, Jiayu D, Feng W Front Oncol. 2025; 14:1398350.

PMID: 39759133 PMC: 11695375. DOI: 10.3389/fonc.2024.1398350.


A 55-year-old man with a cerebral mass.

Ammendola S, Ricciardi G, Barresi V Brain Pathol. 2024; 34(6):e13310.

PMID: 39362771 PMC: 11483508. DOI: 10.1111/bpa.13310.


Primary CNS histiocytic sarcoma: Two case reports highlighting a novel MIGA2::BRAF gene fusion and genome-wide DNA methylation profiling results.

Cecchi R, Guptil D, Haslett N, Hristov A, Bledsoe J, Tsai H J Neuropathol Exp Neurol. 2024; 83(10):882-886.

PMID: 38879442 PMC: 11413427. DOI: 10.1093/jnen/nlae061.

References
1.
Kommalapati A, Tella S, Durkin M, Go R, Goyal G . Histiocytic sarcoma: a population-based analysis of incidence, demographic disparities, and long-term outcomes. Blood. 2017; 131(2):265-268. PMC: 5757688. DOI: 10.1182/blood-2017-10-812495. View

2.
Hung Y, Qian X . Histiocytic Sarcoma. Arch Pathol Lab Med. 2019; 144(5):650-654. DOI: 10.5858/arpa.2018-0349-RS. View

3.
Kim Y, Yie G, Kim N, Jeon I, Cho H, Seok J . Pediatric intracerebral histiocytic sarcoma with rhabdoid features: Case report and literature review. Neuropathology. 2017; 37(6):560-568. DOI: 10.1111/neup.12396. View

4.
May J, Waddle M, Miller D, Stross W, Kaleem T, May B . Primary histiocytic sarcoma of the central nervous system: a case report with platelet derived growth factor receptor mutation and PD-L1/PD-L2 expression and literature review. Radiat Oncol. 2018; 13(1):167. PMC: 6126020. DOI: 10.1186/s13014-018-1115-x. View

5.
Gounder M, Desai V, Kuk D, Agaram N, Arcila M, Durham B . Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas. Eur J Cancer. 2015; 51(16):2413-22. PMC: 5087129. DOI: 10.1016/j.ejca.2015.06.109. View